 <h1>Lynparza Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>olaparib</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about olaparib. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Lynparza.</p><h2>In Summary</h2><p><b>Common side effects of Lynparza include:</b> upper respiratory tract infection, anemia, decreased hemoglobin, increased mcv, increased serum creatinine, nasopharyngitis, nausea, pharyngitis, vomiting, cough, and dyspnea.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to olaparib: oral tablet</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, olaparib (the active ingredient contained in Lynparza) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking olaparib:</p><p>
<i>More common</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bladder pain</li>
<li>bleeding gums</li>
<li>bloody or cloudy urine</li>
<li>body aches or pain</li>
<li>chest pain</li>
<li>chills</li>
<li>cough</li>
<li>cough producing mucus</li>
<li>diarrhea</li>
<li>difficult, burning, or painful urination</li>
<li>difficulty breathing</li>
<li>ear congestion or pain</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>fever</li>
<li>frequent urge to urinate</li>
<li>general feeling of discomfort or illness</li>
<li>head congestion</li>
<li>headache</li>
<li>hoarseness or other voice changes</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>loss of voice</li>
<li>lower back or side pain</li>
<li>muscle aches and pains</li>
<li>nasal congestion</li>
<li>nausea</li>
<li>pain or swelling in the arms or legs</li>
<li>painful or difficult urination</li>
<li>pale skin</li>
<li>pinpoint red spots on the skin</li>
<li>rapid shallow breathing</li>
<li>runny nose</li>
<li>shivering</li>
<li>sneezing</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>sweating</li>
<li>swollen glands</li>
<li>tightness in the chest</li>
<li>trouble sleeping</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Hives, itching, skin rash</li>
<li>irritation</li>
<li>joint stiffness or swelling</li>
<li>redness of the skin</li>
<li>swelling of the eyelids, face, lips, hands, or feet</li>
<li>troubled swallowing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of olaparib may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Back pain</li>
<li>belching</li>
<li>blistering, crusting, irritation, itching, or reddening of the skin</li>
<li>blurred vision</li>
<li>burning, numbness, tingling, or painful sensations</li>
<li>constipation</li>
<li>cracked, dry, or scaly skin</li>
<li>decreased appetite</li>
<li>diarrhea</li>
<li>difficulty with moving</li>
<li>dizziness</li>
<li>dry mouth</li>
<li>fear or nervousness</li>
<li>flushed, dry skin</li>
<li>fruit-like breath odor</li>
<li>heartburn</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>indigestion</li>
<li>lack or loss of strength</li>
<li>loss of bladder control</li>
<li>loss of or change in taste</li>
<li>muscle stiffness</li>
<li>stomach discomfort, upset, or pain</li>
<li>swelling or inflammation of the mouth</li>
<li>unexplained weight loss</li>
<li>unsteadiness or awkwardness</li>
<li>weakness in the arms, hands, legs, or feet</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to olaparib: oral capsule, oral tablet</i></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Myelodysplastic syndrome/Acute Myeloid Leukemia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Decreased hemoglobin (up to 90%), elevated mean corpuscular volume (up to 85%), decreased lymphocytes (up to 56%), anemia (up to 34%), decreased absolute neutrophil count (up to 32%), decreased platelets (up to 30%), neutropenia/febrile neutropenia (17%), leukopenia (13%), thrombocytopenia (11%)</p>
<p><b>Common</b> (1% to 10%): Leukopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis/pharyngitis/upper respiratory infection (up to 43%), cough (up to 21%), dyspnea</p>
<p><b>Common</b> (1% to 10%): Pulmonary embolism</p>
<p><b>Uncommon</b> (0.1% to 1%): Pneumonitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 75%), abdominal pain/discomfort (up to 47%), vomiting (up to 43%), diarrhea (up to 31%), dyspepsia (up to 25%), constipation</p>
<p><b>Common</b> (1% to 10%): Stomatitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/asthenia/lethargy (up to 68%), peripheral edema</p>
<p><b>Common</b> (1% to 10%): Pyrexia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased creatinine (up to 30%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/musculoskeletal pain (up to 32%), myalgia (up to 25%), back pain (up to 25%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, hot flush, venous thrombosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Dermatitis/rash (up to 25%)</p>
<p><b>Common</b> (1% to 10%): Dry skin, eczema, pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection</p>
<p><b>Common</b> (1% to 10%): Dysuria, urinary incontinence, vulvovaginal disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 25%)</p>
<p><b>Common</b> (1% to 10%): Hypomagnesemia, hyperglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 25%), dysgeusia (up to 21%), dizziness</p>
<p><b>Common</b> (1% to 10%): Peripheral neuropathy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, depression, insomnia<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Lynparza (olaparib)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Lynparza (olaparib)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>7 Reviews</li>
<li>Drug class: PARP inhibitors</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lynparza &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Ovarian Cancer</li>
<li>Prostate Cancer</li>
<li>Breast Cancer, Metastatic</li>
<li>Pancreatic Cancer</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to olaparib: oral capsule, oral tablet</i></p><h3>Oncologic</h3><p><b>Uncommon</b> (0.1% to 1%): Myelodysplastic syndrome/Acute Myeloid Leukemia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Decreased hemoglobin (up to 90%), elevated mean corpuscular volume (up to 85%), decreased lymphocytes (up to 56%), anemia (up to 34%), decreased absolute neutrophil count (up to 32%), decreased platelets (up to 30%), neutropenia/febrile neutropenia (17%), leukopenia (13%), thrombocytopenia (11%)</p><p><b>Common</b> (1% to 10%): Leukopenia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Nasopharyngitis/pharyngitis/upper respiratory infection (up to 43%), cough (up to 21%), dyspnea</p><p><b>Common</b> (1% to 10%): Pulmonary embolism</p><p><b>Uncommon</b> (0.1% to 1%): Pneumonitis<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (up to 75%), abdominal pain/discomfort (up to 47%), vomiting (up to 43%), diarrhea (up to 31%), dyspepsia (up to 25%), constipation</p><p><b>Common</b> (1% to 10%): Stomatitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue/asthenia/lethargy (up to 68%), peripheral edema</p><p><b>Common</b> (1% to 10%): Pyrexia<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very common</b> (10% or more): Increased creatinine (up to 30%)<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Arthralgia/musculoskeletal pain (up to 32%), myalgia (up to 25%), back pain (up to 25%)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension, hot flush, venous thrombosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Dermatitis/rash (up to 25%)</p><p><b>Common</b> (1% to 10%): Dry skin, eczema, pruritus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Urinary tract infection</p><p><b>Common</b> (1% to 10%): Dysuria, urinary incontinence, vulvovaginal disorder<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Decreased appetite (up to 25%)</p><p><b>Common</b> (1% to 10%): Hypomagnesemia, hyperglycemia<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 25%), dysgeusia (up to 21%), dizziness</p><p><b>Common</b> (1% to 10%): Peripheral neuropathy<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Anxiety, depression, insomnia<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Lynparza (olaparib)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><h2>More about Lynparza (olaparib)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Espa√±ol</li>
<li>7 Reviews</li>
<li>Drug class: PARP inhibitors</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Lynparza &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Ovarian Cancer</li>
<li>Prostate Cancer</li>
<li>Breast Cancer, Metastatic</li>
<li>Pancreatic Cancer</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>